Online first
Research paper
Published online: 2025-02-24

open access

Page views 104
Article views/downloads 60
Get Citation

Connect on Social Media

Connect on Social Media

Classification of hemostatic methods and their efficacy in placenta increta

Caihong Hu1, Weishe Zhang12, Lijuan Liu1, Xiaowen Zhang1, Hongtao Zeng1, Qi Li1, Jingrui Huang12

Abstract

Introduction: Placenta increta is a serious complication of pregnancy that needs a variety of intraoperative hemostatic methods to stop bleeding. However, the efficacy of different hemostatic methods is still not known. This study aimed to evaluate the efficacy of different hemostatic methods in placenta increta.

Material and methods: A total of 187 placenta increta patients that underwent treatment at Xiangya Hospital Central South University from March 1, 2017 to January 31, 2021 were included in this retrospective study. Perioperative data of patients with placenta increta were retrospectively analyzed. The patients were distributed into two groups according to the hemostasis methods, namely permanent group (n = 29), permanent plus temporary group (n = 158). Permanent hemostasis included the subgroups of uterine hemostasis (e.g., uterine tamponade, B-Lynch suture, and uterine local suture) and vascular hemostasis (e.g., uterine artery ligation and internal iliac artery ligation). The clinical information and maternal-fetal outcomes of the groups and subgroups were analyzed.

Results: A significant difference in blood loss was detected between the permanent hemostasis group and the permanent plus temporary hemostasis group. Compared with the uterine hemostatic, the vascular, and combined hemostatic methods had a significant reduction in postpartum blood loss (p < 0.05). No differences were found within these subgroups in the permanent plus temporary group. Pregnancy outcomes did not differ significantly among the subgroups.

Conclusions: Vascular hemostasis and combined hemostasis may be better than uterine hemostasis alone for placenta increta without temporary hemostasis. Prospective and large-scale studies are needed to investigate long-term outcomes and confirm the efficacy of these hemostatic techniques.

Article available in PDF format

View PDF Download PDF file

References

  1. Yang X, Zheng W, Yan J, et al. High risk factors for placenta accreta other than pregnancy and their impact on patient prognosis. Maternal-Fetal Medicine. 2023; 5(3): 137–143.
  2. Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019; 146(1): 20–24.
  3. Wang CY, Pan HH, Chang CC, et al. Outcomes of hypogastric artery ligation and transcatheter uterine artery embolization in women with postpartum hemorrhage. Taiwan J Obstet Gynecol. 2019; 58(1): 72–76.
  4. Peng ZH, Xiong Z, Zhao BS, et al. Prophylactic abdominal aortic balloon occlusion: An effective method of controlling hemorrhage in patients with placenta previa or accreta. Exp Ther Med. 2019; 17(2): 1492–1496.
  5. Huang J, Zhang X, Liu L, et al. Placenta accreta spectrum outcomes using tourniquet and forceps for vascular control. Front Med (Lausanne). 2021; 8: 557678.
  6. Wang Y, Jiang T, Huang G, et al. Long-term follow-up of abdominal aortic balloon occlusion for the treatment of pernicious placenta previa with placenta accreta. J Interv Med. 2020; 3(1): 34–36.
  7. Şahin H, Soylu Karapınar O, Şahin EA, et al. The effectiveness of the double B-lynch suture as a modification in the treatment of intractable postpartum haemorrhage. J Obstet Gynaecol. 2018; 38(6): 796–799.
  8. Ciavattini A, DI Giuseppe J, Clemente N, et al. Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps. Oncol Lett. 2016; 11(3): 2278–2282.
  9. Zhu L, Lu J, Huang W, et al. A modified suture technique for the treatment of patients with pernicious placenta previa and placenta accreta spectrum: a case series. Ann Transl Med. 2021; 9(14): 1140.
  10. Nabhan AE, AbdelQadir YH, Abdelghafar YA, et al. Therapeutic effect of Internal iliac artery ligation and uterine artery ligation techniques for bleeding control in placenta accreta spectrum patients: A meta-analysis of 795 patients. Front Surg. 2022; 9: 983297.
  11. Kellie FJ, Wandabwa JN, Mousa HA, et al. Mechanical and surgical interventions for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2020; 7(7): CD013663.
  12. Papillon-Smith J, Hobson S, Allen L, et al. Prophylactic internal iliac artery ligation versus balloon occlusion for placenta accreta spectrum disorders: A retrospective cohort study. Int J Gynaecol Obstet. 2020; 151(1): 91–96.
  13. Duan XH, Wang YL, Han XW, et al. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. Clin Radiol. 2015; 70(9): 932–937.
  14. Carnevale FC, Kondo MM, de Oliveira Sousa W, et al. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol. 2011; 34(4): 758–764.
  15. Liu C, Yang DD, Qu HB, et al. Efficacy and safety of prophylactic abdominal aortic balloon occlusion versus internal iliac arterial balloon occlusion for placenta accreta spectrum disorder: A systematic review and meta-analysis. Clin Imaging. 2021; 78: 250–255.
  16. Huang G, Wang X, Yu H, et al. A new surgical technique "cervical internal os plasty" in cesarean delivery for placenta previa accreta: A case-control study. Medicine (Baltimore). 2019; 98(9): e14488.
  17. Meng Y, Wu P, Deng D, et al. Multifaceted spiral suture: A hemostatic technique in managing placenta praevia or accrete: A retrospective study. Medicine (Baltimore). 2017; 96(49): e9101.
  18. Songthamwat S, Songthamwat M. Uterine flexion suture: modified B-Lynch uterine compression suture for the treatment of uterine atony during cesarean section. Int J Womens Health. 2018; 10: 487–492.
  19. Thakur M, Rathore SS, Jindal A, et al. Uterocutaneous fistula following B-Lynch suture for primary postpartum haemorrhage. BMJ Case Rep. 2018.
  20. Brady PC, Soiffer RJ, Ginsburg ES. Continuation of a levonorgestrel intrauterine device during hematopoietic stem cell transplant: a case report. Anticancer Res. 2017; 37(4): 1985–1987.
  21. Healthcare Engineering JOf. Retracted: Effect of Uterine Artery Ligation and Uterine Artery Embolization on Postpartum Hemorrhage Due to Uterine Asthenia after Cesarean Section and Its Effect on Blood Flow and Function of Uterine and Ovarian Arteries. J Healthc Eng. 2023; 2023: 9848967.
  22. Retraction: Randomized controlled trial of the effect of bilateral uterine artery ligation during cesarean among women at risk of uterine atony. International Journal of Gynecology & Obstetrics. 2024; 166(1): 475–475.
  23. Sahu SA, Shrivastava D. Maternal and perinatal outcomes in placenta previa: a comprehensive review of evidence. Cureus. 2024; 16(5): e59737.
  24. Califano G, Saccone G, Maria Maruotti G, et al. Prenatal identification of invasive placentation using ultrasound in women with placenta previa and prior cesarean delivery. Eur J Obstet Gynecol Reprod Biol. 2024; 302: 97–103.
  25. Yang X, Zheng W, Yan J, et al. High risk factors for placenta accreta other than pregnancy and their impact on patient prognosis. Maternal-Fetal Medicine. 2023; 5(3): 137–143.
  26. Wang Q, Ma J, Zhang H, et al. Conservative management versus cesarean hysterectomy in patients with placenta increta or percreta. J Matern Fetal Neonatal Med. 2022; 35(10): 1944–1950.
  27. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018; 132(6): e259–e275.